The IRS is considering a shift that would make it easier for pharmaceutical, technology and other companies to spin off high-risk units without tax consequences—and raising the prospect of further c…
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.
GET DAILY REPORT FREE

